Lonafarnib With and Without Ritonavir in HDV (LOWR-1)

Clinical trial NCT02430181 · COMPLETED

Trial details

NCT number: NCT02430181
Sponsor: Eiger BioPharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Hepatitis D Infection

Start date: 2014-11-01
Primary completion: 2015-09-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.